Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatment

References

• Lengfelder E, Lo-Coco F, Ades L, et al. Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European leukemia Net. Leukemia. 2015;29:1084–1091.
   PubMed Web of Science ®Google Scholar
• Lou Y, Ma Y, Sun J, et al. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients. Ann Hematol. 2015;94(11):1829–1837.
   PubMed Web of Science ®Google Scholar
• Kuo YJ, Liu YJ, Way TD, et al. Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo. ExpTher Med. 2017;13(6):3388–3396.
   PubMed Web of Science ®Google Scholar
• De Thé H, Le Bras M, Lallemand-Breitenbach V. The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. Cell Biol. 2012;198:11–21.
   PubMed Web of Science ®Google Scholar
• Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369(2):111–121.
   PubMed Web of Science ®Google Scholar
• Mathews V, Desire S, George B, et al. Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. Leukemia. 2006;20:881–883.
   PubMed Web of Science ®Google Scholar
• Hao L, Zhao J, Wang X, et al. Hepatotoxicity from arsenic trioxide for pediatric acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2013;35:e67–e70.
   PubMed Web of Science ®Google Scholar
• Kim WR, Flamm SL, Di Bisceglie AM, et al. Public Policy Committee of the American Association for the Study of Liver Disease: Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008;47(4):1363–1370.
   PubMed Web of Science ®Google Scholar
• Traverso N, Ricciarelli R, Nitti M, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013;2013:972913. DOI: https://doi.org/10.1155/2013/972913.
   PubMed Web of Science ®Google Scholar
• Täger M, Ittenson A, Franke A, et al. gamma-Glutamyl trans peptidase-cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias. Ann Hematol. 1995;70(5):237–242.
   PubMed Web of Science ®Google Scholar
• Ishizuka Y, Moriwaki S, Kawahara-Hanaoka M, et al. Treatment with anti-gamma-glutamyl trans peptidase antibody attenuates osteolysis in collagen-induced arthritis mice. J Bone Miner Res. 2007;22(12):1933–1942.
   PubMed Web of Science ®Google Scholar
• Sui M, Zhang Z, Zhou J. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia. Chin Med J (Engl). 2014;127(19):3503–3506.
   PubMed Web of Science ®Google Scholar
• Djavaheri-Mergny M, Accaoui MJ, Rouillard D, et al. Gamma-glutamyl trans peptidase activity mediates NF-kappa B activation through lipid peroxidation in human leukemia U937 cells. Mol Cell Biochem. 2002;232(1–2):103–111.
   PubMed Web of Science ®Google Scholar
• Peng WK, Sheikh Z, Paterson-Brown S, et al. Role of liver function tests in predicting common bile duct stones in acute calculus cholecystitis. Br J Surg. 2005;92:1241–1247.
   PubMed Web of Science ®Google Scholar
• Shizuka Y, Moriwaki S, Kawahara-Hanaoka M, et al. Treatment with anti-gamma-glutamyl trans peptidase antibody attenuates osteolysis in collagen-induced arthritis mice. J Bone Miner Res. 2007;22:1933–1942.
   PubMed Web of Science ®Google Scholar
• Rzymowska J. Activities of enzyme transducing extracellular signals–gamma glutamyltransferase and enzymes metabolizing glutathione in acute lymphoblastic and myeloid human leukemias. Neoplasma. 1995;42:53–56.
   PubMed Web of Science ®Google Scholar
• Cheng YH, Ou BR, Cheng LC, et al. Glutathione regulation in arsenic-induced porcine aortic endothelial cells. Toxicol in Vitro. 2008;22:1832–1839.
   PubMed Web of Science ®Google Scholar
• Giommarelli C, Corti A, Supino R, et al. Gamma-glutamyltransferase-dependent resistance to arsenic trioxide in melanoma cells and cellular sensitization by ascorbic acid. Free Radic Biol Med. 2009;46:1516–1526.
   PubMed Web of Science ®Google Scholar
• Soria EA, Eynard AR, Quiroga PL, et al. Differential effects of quercetin and silymarin on arsenite-induced cytotoxicity in two human breast adenocarcinoma cell lines. Life Sci. 2007;81:1397–1402.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang J, Hu X, et al. Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia. Hematology. 2014;19:202–207.
   PubMed Web of Science ®Google Scholar
• Kwiecień I, Iciek M, Włodek L. Acceleration of anaerobic cysteine transformations to sulfane sulfur consequent to γ-glutamyl transpeptidase inhibition. Sci World J. 2012;2012:253724. DOI: https://doi.org/10.1100/2012/253724.
   Google Scholar
• Hanigan MH. Gamma-glutamyl transpeptidase: redox regulation and drug resistance. Adv Cancer Res. 2014;122:103–141. DOI: https://doi.org/10.1016/B978-0-12-420117-0.00003-7.
   PubMed Web of Science ®Google Scholar
• Khurana H, Meena VK, Prakash S, et al. Preclinical evaluation of a potential GSH ester based PET/SPECT imaging probe DT(GSHMe)₂ to detect gamma glutamyl transferase over expressing tumors. PLoS One. 2015;10:e013428.
   Web of Science ®Google Scholar
• Westerkamp AC, Mahboub P, Meyer SL, et al. End-ischemic machine perfusion reduces bile duct injury in donation after circulatory death rat donor livers independent of the machine perfusion temperature. Liver Transpl. 2015;21(10):1300–1311.
   PubMed Web of Science ®Google Scholar
• Ling S, Xie H, Yang F, et al. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1. J Hematol Oncol. 2017;10 (1):59. DOI: https://doi.org/10.1186/s13045-017-0424-0.
   PubMedGoogle Scholar
• Yang D, Lv Z, Zhang H, et al. Activation of the Nrf2 signaling pathway involving KLF9 Plays a critical role in Allicin resisting against arsenic trioxide-induced hepatotoxicity in rats. Biol Trace Elem Res. 2017;176(1):192–200.
   PubMed Web of Science ®Google Scholar